Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:CHCR NYSE:CSU NASDAQ:HTGM NASDAQ:NTRP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHCRAdvanzeon Solutions$0.00$0.00▼$0.00N/AN/AN/AN/ACSUCapital Senior Living$31.66$8.62▼$58.94$73.49M2.1532,471 shs77 shsHTGMHTG Molecular Diagnostics$6.00$3.50▼$7.95N/A0.99294,806 shs773,040 shsNTRPNextTrip$3.18-5.1%$0.96$0.68▼$3.85$26.62M1.6230,278 shs22,573 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHCRAdvanzeon Solutions0.00%0.00%0.00%0.00%0.00%CSUCapital Senior Living0.00%0.00%0.00%0.00%0.00%HTGMHTG Molecular Diagnostics0.00%0.00%0.00%0.00%0.00%NTRPNextTrip+9.78%-0.89%-6.94%-18.49%+39.58%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHCRAdvanzeon Solutions$0.00$0.00▼$0.00N/AN/AN/AN/ACSUCapital Senior Living$31.66$8.62▼$58.94$73.49M2.1532,471 shs77 shsHTGMHTG Molecular Diagnostics$6.00$3.50▼$7.95N/A0.99294,806 shs773,040 shsNTRPNextTrip$3.18-5.1%$0.96$0.68▼$3.85$26.62M1.6230,278 shs22,573 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHCRAdvanzeon Solutions0.00%0.00%0.00%0.00%0.00%CSUCapital Senior Living0.00%0.00%0.00%0.00%0.00%HTGMHTG Molecular Diagnostics0.00%0.00%0.00%0.00%0.00%NTRPNextTrip+9.78%-0.89%-6.94%-18.49%+39.58%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHCRAdvanzeon Solutions 0.00N/AN/AN/ACSUCapital Senior Living 0.00N/AN/AN/AHTGMHTG Molecular Diagnostics 0.00N/AN/AN/ANTRPNextTrip 1.50Reduce$5.0057.23% UpsideCurrent Analyst Ratings BreakdownLatest CSU, HTGM, NTRP, CHCR, and ODX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/22/2025NTRPNextTripWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/14/2025NTRPNextTripWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025NTRPNextTripWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025NTRPNextTripWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)(Data available from 10/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHCRAdvanzeon SolutionsN/AN/AN/AN/AN/AN/ACSUCapital Senior Living$383.86M0.00N/AN/A($131.19) per share0.00HTGMHTG Molecular Diagnostics$6.37M0.00N/AN/A$2.44 per share0.00NTRPNextTrip$500K53.23N/AN/A$0.71 per share4.48Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHCRAdvanzeon SolutionsN/AN/A0.00N/AN/AN/AN/AN/AN/ACSUCapital Senior Living-$295.37M$49.780.67N/AN/A40.40%N/A-5.64%N/AHTGMHTG Molecular Diagnostics-$21.59MN/A0.00N/AN/A-324.25%45.52%8.93%N/ANTRPNextTrip-$10.12MN/A0.0026.50N/A-1,323.22%-298.91%-139.68%N/ALatest CSU, HTGM, NTRP, CHCR, and ODX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/15/2025Q2 2026NTRPNextTripN/A-$0.39N/A-$0.39N/A$0.76 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCHCRAdvanzeon SolutionsN/AN/AN/AN/AN/ACSUCapital Senior LivingN/AN/AN/AN/AN/AHTGMHTG Molecular DiagnosticsN/AN/AN/AN/AN/ANTRPNextTripN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHCRAdvanzeon SolutionsN/AN/AN/ACSUCapital Senior LivingN/A0.110.11HTGMHTG Molecular DiagnosticsN/A1.401.30NTRPNextTrip0.020.700.70Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHCRAdvanzeon SolutionsN/ACSUCapital Senior Living62.65%HTGMHTG Molecular Diagnostics19.27%NTRPNextTrip3.81%Insider OwnershipCompanyInsider OwnershipCHCRAdvanzeon Solutions16.50%CSUCapital Senior Living5.46%HTGMHTG Molecular Diagnostics2.60%NTRPNextTrip44.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHCRAdvanzeon Solutions2N/AN/ANot OptionableCSUCapital Senior Living3,4162.19 million2.07 millionOptionableHTGMHTG Molecular Diagnostics842.21 million2.16 millionOptionableNTRPNextTrip58.37 million4.64 millionNo DataCSU, HTGM, NTRP, CHCR, and ODX HeadlinesRecent News About These CompaniesNextTrip, Inc. Reports Second Quarter Financial ResultsOctober 17, 2025 | finanznachrichten.deNextTrip, Inc. Reports Second Quarter Financial ResultsOctober 17, 2025 | finanznachrichten.deNextTrip Reports 446% Revenue Surge in Q2 2025October 15, 2025 | tipranks.comNextTrip, Inc. (NASDAQ: NTRP) Reports Second Quarter Financial ResultsOctober 15, 2025 | accessnewswire.comAWhy NextTrip's Content Model Threatens Expedia's DominanceOctober 15, 2025 | accessnewswire.comANextTrip's JOURNY Unveils First Originals Slate as Global Rebrand ExpandsOctober 13, 2025 | accessnewswire.comANextTrip’s JOURNY to debut TIDE food, travel seriesOctober 8, 2025 | msn.comNextTrip's JOURNY to Debut Original Food & Travel Series TIDE, Exclusively on JOURNY Streaming and VOD PlatformsOctober 8, 2025 | accessnewswire.comANextTrip to Present at LD Micro "Main Event" Investor Conference in San Diego, October 19-22, 2025September 30, 2025 | accessnewswire.comANextTrip Expands JOURNY with Launch of VOD Platform, Extending Its Content-to-Commerce EcosystemSeptember 24, 2025 | accessnewswire.comANextTrip Converts Promissory Notes to Preferred StockSeptember 19, 2025 | msn.comNextTrip Completes Series Q Preferred Stock SaleSeptember 16, 2025 | msn.comNextTrip launches Travel Magazine 2.0 platformSeptember 12, 2025 | msn.comNextTrip Launches Travel Magazine 2.0 - A Premium Editorial Platform Connecting Media and BookingSeptember 11, 2025 | accessnewswire.comANextTrip celebrates JOURNY rebranding launchSeptember 3, 2025 | msn.comNextTrip Celebrates Successful JOURNY Rebranding Launch with Growing Advertiser MomentumSeptember 3, 2025 | accessnewswire.comAQ&A: NextTrip COO Ian Sharpe Talks JOURNY TV Relaunch and the Future of FAST and Adventure Travel MediaSeptember 2, 2025 | streamingmedia.comSNextTrip Adjusts Deadlines for 2026 Stockholder MeetingAugust 20, 2025 | tipranks.comNextTrip acquires TA PipelineAugust 12, 2025 | msn.comNextTrip Acquires TA Pipeline for Group Travel ExpansionAugust 12, 2025 | tipranks.comCSU, HTGM, NTRP, CHCR, and ODX Company DescriptionsAdvanzeon Solutions OTCMKTS:CHCRAdvanzeon Solutions, Inc., through its subsidiary, Pharmacy Value Management Solutions, Inc., administers and operates a sleep apnea program known as SleepMaster Solutions. The company was formerly known as Comprehensive Care Corporation and changed its name to Advanzeon Solutions, Inc. in January 2014. Advanzeon Solutions, Inc. was founded in 1969 and is headquartered in Tampa, Florida. On September 8, 2022, the voluntary petition of Advanzeon Solutions, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on September 7, 2020.Capital Senior Living NYSE:CSUCapital Senior Living Corp. engages in the operation of senior housing communities. Its senior living options include independent living, assisted living, and memory care. The company was founded in 1990 and is headquartered in Dallas, TX.HTG Molecular Diagnostics NASDAQ:HTGMHTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. It serves the biopharmaceutical companies, academic research centres, and molecular testing laboratories. Its proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.NextTrip NASDAQ:NTRPNeurotrope, Inc., a biopharmaceutical company, focuses on the development of a product platform for the treatment of Alzheimer's disease. The company's lead product candidate is bryostatin, a natural product isolated from a marine invertebrate organism, a bryozoan called Bugula neritina. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, multiple sclerosis, and niemann-pick type C diseases. The company has a license agreement with The Board of Trustees of the Leland Stanford Junior University for the use of bryostatin structural derivatives, known as bryologs, for use in the treatment of central nervous system disorders, lysosomal storage diseases, stroke, cardio protection, and traumatic brain injury; and a license agreement to an accelerated synthesis of bryostatin-1. Neurotrope, Inc. also has a cooperative research and development agreement with the National Cancer Institute for the research and clinical development of Bryostatin-1. The company was founded in 2012 and is based in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why Intuitive Surgical Is a No-Brainer for Long-Term Investors Why Micron Stock Could Soar 35% on AI Memory Demand WesBanco Insiders Signal Confidence With Coordinated Buys Will D-Wave's European Expansion Keep Fueling the Rally? Can the SharkNinja Rally Continue? Analysts Think So Navitas Soars 78% on NVIDIA Update: Is This Rally Sustainable? Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done Yet Waymo’s Global Expansion Strengthens the Case for GOOGL Stock Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
